Stem cell properties of GT101, a tumor infiltrating lymphocyte (TIL) product with multiple indications. Yarong Liu et. al. Journal of Clinical Oncology 2021 39:15_suppl, e14506-e14506
Perspectives of tumor-infiltrating lymphocyte treatment in solid tumors. Wang, S. et. al. BMC Med 19, 140 (2021)
The toxicity of cell therapy: Mechanism, manifestations, and challenges. Jin Y et. al. J Appl Toxicol. 2021 May;41(5):659-667.